Schedule

This years programme is still in the works and is liable to change.

Day 1

09:30 - 09:50

Registration

Tea, coffee and poster set up.

09:50 - 10:00

Welcome and opening remarks

To be given by Andrew Chalmers and Carly Dix.

Session 1

Chair: Chair-Alison Banham, University of Oxford, UK

10:00 - 10:30

Mathias Uhlén, Royal Institute of Technology (KTH), Sweden

Enhanced validation of antibodies for research applications

10:30 - 10:50

Birte Aggeler, Bio-Techne/R&D Systems, USA

Antibody Validation: New Tools, scientific thinking and common sense

11:00 - 11:30

Break

Tea, coffee, posters and sponsors' exhibition.

Session 2

Chair: Christopher Pudney, University of Bath, UK

11:30 - 12:00

Kathryn Lilley, University of Cambridge, UK

Probing the spatial proteome

12:00 - 12:30

Deepa Shankar, Thermo Fisher Scientific, USA.

Nailing it with Thermo Fisher Scientific’s antibody validation toolbox!

Lunch

12:30 - 13:15

Lunch

13:15 - 14:00

Poster exhibition.

*poster presenters please stand by your poster

Session 3

Chair: Fridtof Lund-Johansen, Oslo University Hospital, Norway

14:00 - 14:30

Richard Goodwin, AstraZeneca, UK

Imaging mass cytometry and multimodal mass spectrometry imaging combined to define drug delivery, metabolism and response

14:30 - 15:00

Alejandra Solache, Abcam, UK

Title TBC

15:00 - 15:30

Break

Tea, coffee, posters and sponsors' exhibition.

Session 4

Chair: Arthur Lewis, MedImmune, UK

15:30 - 16:00

Jan Roger, GSK, UK

The approaches GSK are using to ensure antibodies are fit for purpose for target identification/validation.

16:00 - 16:30

Jason Li, Proteintech, USA

Title TBC

Discussion forum

Chair: James Hunt, AstraZeneca, UK.

16:30 - 18:00

Part 1: What can suppliers do to improve antibody validation?

The panel will include: Birte Aggeler (Bio-Techne/R&D Systems), Deepa Shankar (Thermo Fisher Scientific), Alejandra Solache (Abcam), Roberto Polakiewicz (Cell Signaling Technology) and Jason Li, Proteintech.


Part 2: What can end users do to improve antibody validation?


The panel will include: Mathias Uhlen (Royal Institute of Technology KTH), Alison Banham (University of Oxford), Stephen Hearty (Immunocore), Karine Enesa (AstraZeneca), Dagmar Ernhofer (BioMed X) and Fridtof Lund-Johansen Oslo University Hospital (TBC).

All delegates will be invited to ask questions and join in the discussion.

19:30 - late

Conference social event.

The evening starts at 7.30pm with a meal at Brasserie Blanc in central Bath. If you haven't booked yet but would still like to come, please drop us an email

This years programme is still in the works and is liable to change.

Day 2

08:30 - 09:00

Open

Tea, coffee and poster set up.

Session 5

Chair: Stephen Hearty, Immunocore, UK

09:00 - 09:30

Roberto Polakiewicz, Cell Signaling Technology, USA

The science behind antibody validation at Cell Signaling Technology.

09:30 - 09:50

Selected abstract talk

Title TBC

09:50 - 10:20

Dagmar Ehrnhoefer, BioMed X, Germany.

Validation of post-translational modification specific antibodies for non-histone proteins

10:20 - 10:50

Break

Tea, coffee, posters and sponsors' exhibition

Session 6

Chair: Carly Dix, AstraZeneca, UK

10:50 - 11:10

Selected abstract talk

Title TBC

11:10 - 11:40

Gemma Jones, Astra Zeneca, UK.

Validation of clinical IHC biomarker assays for translational science.

11:40 - 11:50

Closing remarks

To be given by Andrew Chalmers and Carly Dix